Ballentine Partners’s Aralez Pharmaceuticals Inc. ARLZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-50,000
| Closed | -$18K | – | 382 |
|
|
2018
Q2 | $18K | Sell |
50,000
-50,000
| -50% | -$18K | ﹤0.01% | 341 |
|
|
2018
Q1 | $150K | Buy |
100,000
+3,800
| +4% | +$5.7K | 0.01% | 336 |
|
|
2017
Q4 | $137K | Buy |
96,200
+16,200
| +20% | +$23.1K | 0.01% | 349 |
|
|
2017
Q3 | $183K | Buy |
80,000
+50,000
| +167% | +$114K | 0.01% | 358 |
|
|
2017
Q2 | $41K | Buy |
+30,000
| New | +$41K | ﹤0.01% | 411 |
|